Related Experiment Video
Updated: Mar 27, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Extended survival in stage IV adrenocortical carcinoma with recurrence and bone metastases
Joseph T Lehmann1, Patrick Klang2, Assef Jawaada2
1Endocrine Surgery, King's College Hospital NHS Foundation Trust, London, England, UK JTLehmann@gmail.com.
Abstract:
Adrenocortical carcinomas (ACCs) are rare aggressive endocrine tumours that commonly spread to the lymph nodes, liver and lung. Infrequently they metastasise to the bone and when present are often fatal.We report the case of a middle-aged male with a 23 cm ACC with extensive liver metastases at presentation. Index management was a two-stage procedure with resection of the primary lesion en bloc followed by hepatectomy with radiofrequency ablation to inoperable metastases. He had recurrence of disease with a left femur metastasis and additional liver metastases. Remission was obtained with radiotherapy, chemotherapy, bone resorptive inhibitors, mitotane and repeat radiofrequency ablation. He was discharged from regular surveillance and remains alive and free of active disease 14 years after initial diagnosis. To our knowledge, this is the longest recorded survival of a patient with stage IV ACC with recurrent disease and bone metastases.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Cancer Survival Analysis
